Neurogenic oedema and vasodilatation: Effect of a selective neuronal NO inhibitor

NeuroReport

Volumn 9, Issue 7, 1998, Pages 1513-1518

  Towler, P K ^a,b   Bennett, G S ^a,c   Moore, P K ^a   Brain, S D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MRC Pfizer

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CGRP; Neurogenic inflammation; Neuronal nitric oxide synthase; Nitric oxide; nNOS; NO; Rat saphenous nerve; Substance P; Trifluoromethlyphenyl imidazole; TRIM

Indexed keywords

1 (2 TRIFLUOROMETHYLPHENYL)IMIDAZOLE; 2 TRIFLUOROMETHYLPHENOL; CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SUBSTANCE P; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ELECTROSTIMULATION; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SAPHENOUS NERVE; SKIN EDEMA; VASODILATATION;

EID: 0032507668     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199805110-00049     Document Type: Article

References (18)

1. Lembeck F and Holzer P. Naunyn Schmeideberg's Arch Pharmacol 310, 175-183 (1979).
2. Emonds-Alt X, Doutremepuich J-D, Heaulme M et al., Eur J Pharmacol 250, 403-413 (1993).
3. Lembeck F, Donnerer J, Tsuchiya M et al. Br J Pharmacol 105, 527-530 (1992).
4. Chiba C, Yamaguchi A, Yamatani T et al. Am J Physiol 256, E331-E335 (1989).
5. Delay-Goyet P, Satoh H, and Lundberg JM. Acta Physiol Scand 146, 537-538 (1992).
6. Escott KJ and Brain SD. Br J Pharmacol 110, 772-776 (1993).
7. Hughes SR and Brain SD. Br J Pharmacol 111, 425-430 (1994).
8. Ravelic V, Khalil Z, Dusting GJ et al. Br J Pharmacol 108, 650-655 (1992).
9. Moore PK, Wallace P, Gaffen Z et al Br J Pharmacol, B110, 219-224 (1993).
10. Moore PK, Wallace P, Gaffen Z et al. Br J Pharmacol 108, 296-297 (1993).
11. Kajekar R, Moore PK and Brain SD. Circ Res 76, 441-447 (1994).
12. Handy RLC, Wallace P, Gaffen ZA et al. Br J Pharmacol 116, 2349-2350 (1995).
13. Handy RLC, Harb HL, Wallace P et al. Br J Pharmacol 119, 423-431 (1996).
14. Handy RLC and Moore PK. Life Sci 60, PL389-PL394 (1997).
15. Meller ST and Gebhart GF. Pain 52, 127-136 (1993).
16. Benrath, J Eschenfelder, C Zimmerman M et al. Eur J Pharmacol 293, 87-96 (1995).
17. Lassen LH, Ashina M, Christiansen I et al. Lancet 349, 401-402 (1997).
18. Buzzi MG and Moskowitz MA. Br J Pharmacol 99, 202-206 (1990).